XML 26 R16.htm IDEA: XBRL DOCUMENT v3.22.1
Other Financial Information
 3 Months Ended
Apr. 03, 2022
Other Financial Information [Abstract]  
Other Financial Information Other Financial Information
A. Inventories
The following summarizes the components of Inventories:
(MILLIONS)April 3,
2022		December 31, 2021
Finished goods$3,633 $3,641 
Work-in-process4,843 4,424 
Raw materials and supplies1,502 994 
Inventories(a)
$9,979 $9,059 
Noncurrent inventories not included above(b)
$894 $939 
(a)The change from December 31, 2021 reflects increases for Paxlovid and Comirnaty, as well as increases for certain products mainly for network strategy and supply recovery, partially offset by decreases due to market demand.
(b)Included in Other noncurrent assets. There are no recoverability issues for these amounts.
B. Other Current Liabilities
Other current liabilities includes, among other things, amounts payable to BioNTech for the gross profit split for Comirnaty, which totaled $10.0 billion as of April 3, 2022 and $9.7 billion as of December 31, 2021.